Table 1.
HIV-1 Proteases | IC50 of HIV-1 protease inhibitors * in nM | ||||||||
---|---|---|---|---|---|---|---|---|---|
DRV | ATV | LPV | TPV | NFV | APV | SQV | IDV | RTV | |
NL4-3 | 0.26 | 0.19 | 0.28 | 0.24 | 1.6 | 0.43 | 0.50 | 0.47 | 0.34 |
MDR 769 | 0.74 | 2.9 | 0.50 | 0.65 | 110 | 4.8 | 290 | 120 | 61 |
MDR 807 | 2.0 | 7.6 | 1.2 | 0.63 | 210 | 2.9 | 850 | 280 | 14.6 |
MDR 1385 | 3.0 | 4.6 | 2.3 | 2.8 | 230 | 3.1 | 29 | 140 | 8.0 |
MDR 3761 | 0.89 | 2.2 | 0.39 | 0.63 | 430 | 4.1 | 110 | 210 | 21 |
Inhibitor abbreviations: DRV (darunavir), ATV (atazanavir), LPV (lopinavir), TPV (tipranavir), NFV (nelfinavir), APV (amprenavir), SQV (saquinavir), IDV (indinavir), RTV (ritonavir). * The protease inhibitors were requested from the NIH AIDS Research and Reference Reagent Program (www.aidsreagent.org).